Barrett’s esophagus is diagnosed in 5-15% of patients with gastroesophageal reflux disease. It is often a precursor to esophageal adenocarcinoma, however the condition often goes undiagnosed. Patients with reflux disease who are male, over age 50, are white, and who smoke or have central obesity or a family history of Barrett esophagus or esophageal adenocarcinoma, should undergo initial screening endoscopy and, if no dysplasia is noted, surveillance endoscopy every 3 to 5 years. Dysplasia is treated with endoscopic eradication by ablation, resection, or both.

Released: August 2020
Viewing Time: 1 hour 33 minutes

HOST(s):
Amitabh Chak, MD, FASGE
Prateek Sharma, MD, FASGE
Marcia Canto, MD, MHS, FASGE

MODERATOR(s):
Neal Mehta, MD, GI Fellow
Judy Trieu, MD, GI Fellow